The engagement of key opinion leaders (KOLs) is critical for pharmaceutical companies to develop their clinical research programs and for strategic planning. Historically, identifying KOLs has relied on personal recommendations as well as tools and services that aggregate metrics about the impact of a researcher. While such approaches have been adopted widely and proven … [Read more...]